Teva Respiratory, an affiliate of Teva Pharmaceutical Industries, completed its digital inhaler portfolio today with the launch of two new products: the AirDuo Digihaler and the ArmonAir Digihaler.

A new inhaler that treats chronic obstructive pulmonary disease (COPD) and also helps reduce environmental harm has been approved for use in the UK. This inhaler is already available in India.

What to do when a patient’s asthma control deteriorates after switching to a more environmentally friendly, or ‘greener’, ...

For many children, asthma can be a constant specter, with attacks at the most inconvenient and terrifying times. New research has now found that one inhaler containing two drugs can cut the risk of ...

Early fall is when asthma flare-ups peak in the US, and a warming climate is bad news for sufferers: It means more ground-level ozone, a longer pollen season and more wildfire smoke - all triggers for ...

Millions of people depend on asthma inhalers, but most people don't know that using those inhalers creates a carbon footprint. That's according to a new study published in the medical journal JAMA ...